Effect of Low-level Laser Therapy on Oral Keratinocytes Exposed to Bisphosphonate

Overview

Journal Lasers Med Sci

Publisher Springer

Date 2013 Jul 10

PMID 23835780

Citations 9

Authors

Jae-Yeol Lee

In-Ryoung Kim

Bong-Soo Park

Yong-Deok Kim

In-Kyo Chung

Jae-Min Song

Sang-Hun Shin

Affiliations

Soon will be listed here.

Abstract

Bisphosphonate-related osteonecrosis of the jaw (BRONJ) is a side effect of bisphosphonate therapy. However, its pathophysiology is not yet fully elucidated, and effective treatment of BRONJ remains unclear. The aim of this study is to investigate the effects of alendronate on oral keratinocytes and of low-level laser therapy (LLLT) on alendronate-treated keratinocytes, specifically by evaluating their viability, apoptosis, and wound healing function after irradiation. Oral keratinocyte cells (HaCaT) were exposed to 25 μM alendronate. Then, laser irradiation was performed with a low-level Ga-Al-As laser (λ = 808 ± 3 nm, 80 mW, and 80 mA; NDLux, Seoul, Korea) using 1.2 J/cm(2) energy dose. Viability was analyzed using MTT assay. Apoptosis was measured by Hoechst staining, caspase assay. Changes in secretion of IL-8, VEGF, and collagen type I were studied by ELISA and immunofluorescence microscopy. Scratch wound assays were also performed to measure cellular migration. Our results show that alendronate inhibits keratinocyte viability, expression of IL-8, VEGF, and collagen type I which are intimately related to healing events and cell migration while promoting apoptosis. Our results serve to demonstrate the utility of LLLT in partially overcoming the inhibitory effects of this bisphosphonate. From these results, the authors believe that the present study will provide an experimental basis for a fuller explanation of the clinical effects of LLLT as a BRONJ treatment modality.

Citing Articles

Laser Devices and Autologous Platelet Concentrates in Prevention and Treatment of Medication-Related Osteonecrosis of the Jaws: A Systematic Review.

Scribante A, Ghizzoni M, Pellegrini M, Pulicari F, Spadari F Medicina (Kaunas). 2023; 59(5).

PMID: 37241204 PMC: 10221057. DOI: 10.3390/medicina59050972.

Management of Medication-Related Osteonecrosis of the Jaw (MRONJ) Using Leukocyte- and Platelet-Rich Fibrin (L-PRF) and Photobiomodulation: A Retrospective Study.

Tenore G, Zimbalatti A, Rocchetti F, Graniero F, Gaglioti D, Mohsen A J Clin Med. 2020; 9(11).

PMID: 33138266 PMC: 7693575. DOI: 10.3390/jcm9113505.

The Effectiveness of the Low-Level Laser, Antibiotic and Surgical Therapy in the Treatment of Medication-Related Osteonecrosis of the Jaws: A Case Report.

Rodriguez-Sanchez M, Statkievicz C, Mello-Neto J, Toro L, Bassi A, Garcia V J Lasers Med Sci. 2020; 11(1):98-103.

PMID: 32099634 PMC: 7008748. DOI: 10.15171/jlms.2020.16.

Photobiomodulation Elicits a Differential Cytokine Response in a Cultured Analogue of Human Skin.

Prindeze N, Ardanuy J, Carney B, Moffatt L, Shupp J Eplasty. 2019; 19:e3.

PMID: 30858901 PMC: 6404725.

A brief literature review and own clinical experience in prophylaxis of oral mucositis in children using low level laser therapy.

Moskvin S, Pritiko D, Sergeenko E, Lukash E, Gusev L Biomedicine (Taipei). 2019; 9(1):1.

PMID: 30794148 PMC: 6385611. DOI: 10.1051/bmdcn/2019090101.

References

Ruggiero S, Mehrotra B, Rosenberg T, Engroff S . Osteonecrosis of the jaws associated with the use of bisphosphonates: a review of 63 cases. J Oral Maxillofac Surg. 2004; 62(5):527-34. DOI: 10.1016/j.joms.2004.02.004. View

Dadpay M, Sharifian Z, Bayat M, Bayat M, Dabbagh A . Effects of pulsed infra-red low level-laser irradiation on open skin wound healing of healthy and streptozotocin-induced diabetic rats by biomechanical evaluation. J Photochem Photobiol B. 2012; 111:1-8. DOI: 10.1016/j.jphotobiol.2012.03.001. View

Marques M, Pereira A, Fujihara N, Nogueira F, Eduardo C . Effect of low-power laser irradiation on protein synthesis and ultrastructure of human gingival fibroblasts. Lasers Surg Med. 2004; 34(3):260-5. DOI: 10.1002/lsm.20008. View

Kim R, Lee R, Williams D, Bae S, Woo J, Lieberman M . Bisphosphonates induce senescence in normal human oral keratinocytes. J Dent Res. 2011; 90(6):810-6. PMC: 3144120. DOI: 10.1177/0022034511402995. View

Landesberg R, Woo V, Cremers S, Cozin M, Marolt D, Vunjak-Novakovic G . Potential pathophysiological mechanisms in osteonecrosis of the jaw. Ann N Y Acad Sci. 2011; 1218:62-79. PMC: 4477826. DOI: 10.1111/j.1749-6632.2010.05835.x. View

de Groen P, Lubbe D, Hirsch L, Daifotis A, STEPHENSON W, Freedholm D . Esophagitis associated with the use of alendronate. N Engl J Med. 1996; 335(14):1016-21. DOI: 10.1056/NEJM199610033351403. View

Abu-Id M, Acil Y, Gottschalk J, Kreusch T . [Bisphosphonate-associated osteonecrosis of the jaw]. Mund Kiefer Gesichtschir. 2006; 10(2):73-81. DOI: 10.1007/s10006-005-0670-0. View

Hakkinen L, Uitto V, Larjava H . Cell biology of gingival wound healing. Periodontol 2000. 2001; 24:127-52. View

Zhang L, Xing D, Gao X, Wu S . Low-power laser irradiation promotes cell proliferation by activating PI3K/Akt pathway. J Cell Physiol. 2009; 219(3):553-62. DOI: 10.1002/jcp.21697. View

10.

Scheper M, Badros A, Chaisuparat R, Cullen K, Meiller T . Effect of zoledronic acid on oral fibroblasts and epithelial cells: a potential mechanism of bisphosphonate-associated osteonecrosis. Br J Haematol. 2008; 144(5):667-76. PMC: 2739302. DOI: 10.1111/j.1365-2141.2008.07504.x. View

11.

Bayram H, Kenar H, Tasar F, Hasirci V . Effect of low level laser therapy and zoledronate on the viability and ALP activity of Saos-2 cells. Int J Oral Maxillofac Surg. 2012; 42(1):140-6. DOI: 10.1016/j.ijom.2012.03.026. View

12.

Shefer G, Oron U, Irintchev A, Wernig A, Halevy O . Skeletal muscle cell activation by low-energy laser irradiation: a role for the MAPK/ERK pathway. J Cell Physiol. 2001; 187(1):73-80. DOI: 10.1002/1097-4652(2001)9999:9999<::AID-JCP1053>3.0.CO;2-9. View

13.

Pabst A, Ziebart T, Koch F, Taylor K, Al-Nawas B, Walter C . The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study. Clin Oral Investig. 2011; 16(1):87-93. DOI: 10.1007/s00784-010-0507-6. View

14.

Rubegni P, Fimiani M . Images in clinical medicine. Bisphosphonate-associated contact stomatitis. N Engl J Med. 2006; 355(22):e25. DOI: 10.1056/NEJMicm054413. View

15.

Eming S, Brachvogel B, Odorisio T, Koch M . Regulation of angiogenesis: wound healing as a model. Prog Histochem Cytochem. 2007; 42(3):115-70. DOI: 10.1016/j.proghi.2007.06.001. View

16.

Goldman L, Goldman B, Van Lieu N . Current laser dentistry. Lasers Surg Med. 1987; 6(6):559-62. DOI: 10.1002/lsm.1900060616. View

17.

Marx R, Cillo Jr J, Ulloa J . Oral bisphosphonate-induced osteonecrosis: risk factors, prediction of risk using serum CTX testing, prevention, and treatment. J Oral Maxillofac Surg. 2007; 65(12):2397-410. DOI: 10.1016/j.joms.2007.08.003. View

18.

Reid I, Bolland M, Grey A . Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity?. Bone. 2007; 41(3):318-20. DOI: 10.1016/j.bone.2007.04.196. View

19.

Ohnuki H, Izumi K, Terada M, Saito T, Kato H, Suzuki A . Zoledronic acid induces S-phase arrest via a DNA damage response in normal human oral keratinocytes. Arch Oral Biol. 2011; 57(7):906-17. DOI: 10.1016/j.archoralbio.2011.11.015. View

20.

Marx R . Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg. 2003; 61(9):1115-7. DOI: 10.1016/s0278-2391(03)00720-1. View